Listed

Savara Inc

SVRANasdaqCIK 1160308HealthcareFiscal year ends Dec 31

Reports and events: 402 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Savara Inc, Reports and events
FiledFormWhat it isAccession number
2026-08-1116:05 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-344585
2026-06-0816:15 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-26-261770
2026-05-1216:05 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-219371
2026-04-2416:22 ETDEF 14AProxy statementPeriod 2026-06-040001193125-26-177353
2026-03-1308:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-26-105099
2026-03-1308:10 ET10-KAnnual reportPeriod 2025-12-310001193125-26-105076
2026-01-2708:10 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193125-26-023378
2026-01-0908:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-008301
2025-11-1416:27 ETSCHEDULE 13D/AOwnership report, active investor, amended0001072613-25-000852
2025-11-1216:05 ET10-QQuarterly reportPeriod 2025-09-300001193125-25-277525
2025-10-3016:26 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-258629
2025-10-2916:03 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-256290
2025-09-0209:13 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-193507
2025-08-1308:05 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-107631
2025-06-0616:48 ET8-K5.07 Shareholder vote results0001193125-25-137150
2025-05-2708:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-126273
2025-05-1316:03 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-070283
2025-04-2516:18 ETDEF 14AProxy statementPeriod 2025-06-050001193125-25-096895
2025-04-2516:03 ET10-K/AAnnual report, amendedPeriod 2024-12-310000950170-25-058690
2025-03-3106:09 ET8-K1.02 Termination of a material agreement0001193125-25-067658
2025-03-2717:40 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-046213
2025-03-2707:30 ET10-KAnnual reportPeriod 2024-12-310000950170-25-045731
2025-03-2617:01 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-064145
2025-01-2316:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-25-011453
2025-01-1308:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-005034
2024-11-1216:00 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-125292
2024-08-1420:45 ETSC 13D/AOwnership report, active investor, amended0001072613-24-000639
2024-08-1216:05 ET10-QQuarterly reportPeriod 2024-06-300000950170-24-095403
2024-06-2810:10 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-171564
2024-06-2606:40 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-168501
2024-06-1017:07 ET8-K/A5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-24-158429
2024-06-0716:15 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-24-157366
2024-05-0916:10 ET10-QQuarterly reportPeriod 2024-03-310000950170-24-056954
2024-04-2616:14 ETDEF 14AProxy statementPeriod 2024-06-060001193125-24-118077
2024-04-1217:26 ETSC 13D/AOwnership report, active investor, amended0001193125-24-094908
2024-04-1216:07 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events0001193125-24-094640
2024-03-0716:05 ET10-KAnnual reportPeriod 2023-12-310000950170-24-027920
2024-02-1608:31 ET8-K1.01 Entry into a material agreement0001193125-24-038108
2024-01-2516:06 ET8-K5.02 Departure or appointment of officers or directors0001193125-24-015391
2024-01-0508:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-002889
2023-11-0916:10 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-062040
2023-08-1016:11 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-041323
2023-07-2616:57 ETSC 13D/AOwnership report, active investor, amended0001072613-23-000396
2023-07-1916:30 ETSC 13D/AOwnership report, active investor, amended0001193125-23-189644
2023-07-1317:18 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-186640
2023-06-0908:02 ET8-K5.07 Shareholder vote results0001193125-23-164012
2023-06-0816:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-163526
2023-05-1508:15 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021981
2023-04-2816:12 ETDEF 14AProxy statementPeriod 2023-06-080001193125-23-126955
2023-03-3017:14 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-23-085762

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.